 | • レポートコード：GIR-107A12595 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ポルフィリン症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ポルフィリン症治療の種類別市場規模（ポルフィリン、デキストロース、抗けいれん薬、オピオイド、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ポルフィリン症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Lundbeck、Recordati Rare Diseases、Teva Pharmaceutical、Apotex ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ポルフィリン、デキストロース、抗けいれん薬、オピオイド、その他 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・ポルフィリン症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ポルフィリン症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ポルフィリン症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ポルフィリン症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ポルフィリン症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Porphyrias Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Porphyrias Treatments size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Porphyrias Treatments market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Porphyrias Treatments market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Porphyrin
Dextrose
Anticonvulsants
Opioids
Others
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Lundbeck
Recordati Rare Diseases
Teva Pharmaceutical
Apotex
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Porphyrias Treatments
1.2 Classification of Porphyrias Treatments by Type
1.2.1 Overview: Global Porphyrias Treatments Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Porphyrias Treatments Revenue Market Share by Type in 2020
1.2.3 Porphyrin
1.2.4 Dextrose
1.2.5 Anticonvulsants
1.2.6 Opioids
1.2.7 Others
1.3 Global Porphyrias Treatments Market by Application
1.3.1 Overview: Global Porphyrias Treatments Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Porphyrias Treatments Market Size & Forecast
1.5 Global Porphyrias Treatments Market Size and Forecast by Region
1.5.1 Global Porphyrias Treatments Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Porphyrias Treatments Market Size by Region, (2016-2021)
1.5.3 North America Porphyrias Treatments Market Size and Prospect (2016-2026)
1.5.4 Europe Porphyrias Treatments Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Porphyrias Treatments Market Size and Prospect (2016-2026)
1.5.6 South America Porphyrias Treatments Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Porphyrias Treatments Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Porphyrias Treatments Market Drivers
1.6.2 Porphyrias Treatments Market Restraints
1.6.3 Porphyrias Treatments Trends Analysis
2 Company Profiles
2.1 Lundbeck
2.1.1 Lundbeck Details
2.1.2 Lundbeck Major Business
2.1.3 Lundbeck Porphyrias Treatments Product and Solutions
2.1.4 Lundbeck Porphyrias Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Lundbeck Recent Developments and Future Plans
2.2 Recordati Rare Diseases
2.2.1 Recordati Rare Diseases Details
2.2.2 Recordati Rare Diseases Major Business
2.2.3 Recordati Rare Diseases Porphyrias Treatments Product and Solutions
2.2.4 Recordati Rare Diseases Porphyrias Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Recordati Rare Diseases Recent Developments and Future Plans
2.3 Teva Pharmaceutical
2.3.1 Teva Pharmaceutical Details
2.3.2 Teva Pharmaceutical Major Business
2.3.3 Teva Pharmaceutical Porphyrias Treatments Product and Solutions
2.3.4 Teva Pharmaceutical Porphyrias Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Teva Pharmaceutical Recent Developments and Future Plans
2.4 Apotex
2.4.1 Apotex Details
2.4.2 Apotex Major Business
2.4.3 Apotex Porphyrias Treatments Product and Solutions
2.4.4 Apotex Porphyrias Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Apotex Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Porphyrias Treatments Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Porphyrias Treatments Players Market Share
3.2.2 Top 10 Porphyrias Treatments Players Market Share
3.2.3 Market Competition Trend
3.3 Porphyrias Treatments Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Porphyrias Treatments Revenue and Market Share by Type (2016-2021)
4.2 Global Porphyrias Treatments Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Porphyrias Treatments Revenue Market Share by Application (2016-2021)
5.2 Porphyrias Treatments Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Porphyrias Treatments Revenue by Type (2016-2026)
6.2 North America Porphyrias Treatments Revenue by Application (2016-2026)
6.3 North America Porphyrias Treatments Market Size by Country
6.3.1 North America Porphyrias Treatments Revenue by Country (2016-2026)
6.3.2 United States Porphyrias Treatments Market Size and Forecast (2016-2026)
6.3.3 Canada Porphyrias Treatments Market Size and Forecast (2016-2026)
6.3.4 Mexico Porphyrias Treatments Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Porphyrias Treatments Revenue by Type (2016-2026)
7.2 Europe Porphyrias Treatments Revenue by Application (2016-2026)
7.3 Europe Porphyrias Treatments Market Size by Country
7.3.1 Europe Porphyrias Treatments Revenue by Country (2016-2026)
7.3.2 Germany Porphyrias Treatments Market Size and Forecast (2016-2026)
7.3.3 France Porphyrias Treatments Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Porphyrias Treatments Market Size and Forecast (2016-2026)
7.3.5 Russia Porphyrias Treatments Market Size and Forecast (2016-2026)
7.3.6 Italy Porphyrias Treatments Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Porphyrias Treatments Revenue by Type (2016-2026)
8.2 Asia-Pacific Porphyrias Treatments Revenue by Application (2016-2026)
8.3 Asia-Pacific Porphyrias Treatments Market Size by Region
8.3.1 Asia-Pacific Porphyrias Treatments Revenue by Region (2016-2026)
8.3.2 China Porphyrias Treatments Market Size and Forecast (2016-2026)
8.3.3 Japan Porphyrias Treatments Market Size and Forecast (2016-2026)
8.3.4 South Korea Porphyrias Treatments Market Size and Forecast (2016-2026)
8.3.5 India Porphyrias Treatments Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Porphyrias Treatments Market Size and Forecast (2016-2026)
8.3.7 Australia Porphyrias Treatments Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Porphyrias Treatments Revenue by Type (2016-2026)
9.2 South America Porphyrias Treatments Revenue by Application (2016-2026)
9.3 South America Porphyrias Treatments Market Size by Country
9.3.1 South America Porphyrias Treatments Revenue by Country (2016-2026)
9.3.2 Brazil Porphyrias Treatments Market Size and Forecast (2016-2026)
9.3.3 Argentina Porphyrias Treatments Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Porphyrias Treatments Revenue by Type (2016-2026)
10.2 Middle East & Africa Porphyrias Treatments Revenue by Application (2016-2026)
10.3 Middle East & Africa Porphyrias Treatments Market Size by Country
10.3.1 Middle East & Africa Porphyrias Treatments Revenue by Country (2016-2026)
10.3.2 Turkey Porphyrias Treatments Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Porphyrias Treatments Market Size and Forecast (2016-2026)
10.3.4 UAE Porphyrias Treatments Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Porphyrias Treatments Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Porphyrias Treatments Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Porphyrias Treatments Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Porphyrias Treatments Revenue (USD Million) by Region (2016-2021)
Table 5. Global Porphyrias Treatments Revenue Market Share by Region (2021-2026)
Table 6. Lundbeck Corporate Information, Head Office, and Major Competitors
Table 7. Lundbeck Major Business
Table 8. Lundbeck Porphyrias Treatments Product and Solutions
Table 9. Lundbeck Porphyrias Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Recordati Rare Diseases Corporate Information, Head Office, and Major Competitors
Table 11. Recordati Rare Diseases Major Business
Table 12. Recordati Rare Diseases Porphyrias Treatments Product and Solutions
Table 13. Recordati Rare Diseases Porphyrias Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Teva Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 15. Teva Pharmaceutical Major Business
Table 16. Teva Pharmaceutical Porphyrias Treatments Product and Solutions
Table 17. Teva Pharmaceutical Porphyrias Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Apotex Corporate Information, Head Office, and Major Competitors
Table 19. Apotex Major Business
Table 20. Apotex Porphyrias Treatments Product and Solutions
Table 21. Apotex Porphyrias Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global Porphyrias Treatments Revenue (USD Million) by Players (2019-2021)
Table 23. Global Porphyrias Treatments Revenue Share by Players (2019-2021)
Table 24. Breakdown of Porphyrias Treatments by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. Porphyrias Treatments Players Head Office, Products and Services Provided
Table 26. Porphyrias Treatments Mergers & Acquisitions in the Past Five Years
Table 27. Porphyrias Treatments New Entrants and Expansion Plans
Table 28. Global Porphyrias Treatments Revenue (USD Million) by Type (2016-2021)
Table 29. Global Porphyrias Treatments Revenue Share by Type (2016-2021)
Table 30. Global Porphyrias Treatments Revenue Forecast by Type (2021-2026)
Table 31. Global Porphyrias Treatments Revenue by Application (2016-2021)
Table 32. Global Porphyrias Treatments Revenue Forecast by Application (2021-2026)
Table 33. North America Porphyrias Treatments Revenue by Type (2016-2021) & (USD Million)
Table 34. North America Porphyrias Treatments Revenue by Type (2021-2026) & (USD Million)
Table 35. North America Porphyrias Treatments Revenue by Application (2016-2021) & (USD Million)
Table 36. North America Porphyrias Treatments Revenue by Application (2021-2026) & (USD Million)
Table 37. North America Porphyrias Treatments Revenue by Country (2016-2021) & (USD Million)
Table 38. North America Porphyrias Treatments Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe Porphyrias Treatments Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe Porphyrias Treatments Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe Porphyrias Treatments Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe Porphyrias Treatments Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe Porphyrias Treatments Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe Porphyrias Treatments Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific Porphyrias Treatments Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific Porphyrias Treatments Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific Porphyrias Treatments Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific Porphyrias Treatments Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific Porphyrias Treatments Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific Porphyrias Treatments Revenue by Region (2021-2026) & (USD Million)
Table 51. South America Porphyrias Treatments Revenue by Type (2016-2021) & (USD Million)
Table 52. South America Porphyrias Treatments Revenue by Type (2021-2026) & (USD Million)
Table 53. South America Porphyrias Treatments Revenue by Application (2016-2021) & (USD Million)
Table 54. South America Porphyrias Treatments Revenue by Application (2021-2026) & (USD Million)
Table 55. South America Porphyrias Treatments Revenue by Country (2016-2021) & (USD Million)
Table 56. South America Porphyrias Treatments Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa Porphyrias Treatments Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa Porphyrias Treatments Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa Porphyrias Treatments Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa Porphyrias Treatments Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa Porphyrias Treatments Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa Porphyrias Treatments Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Porphyrias Treatments Picture
Figure 2. Global Porphyrias Treatments Revenue Market Share by Type in 2020
Figure 3. Porphyrin
Figure 4. Dextrose
Figure 5. Anticonvulsants
Figure 6. Opioids
Figure 7. Others
Figure 8. Porphyrias Treatments Revenue Market Share by Application in 2020
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global Porphyrias Treatments Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Porphyrias Treatments Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Porphyrias Treatments Revenue Market Share by Region (2016-2026)
Figure 15. Global Porphyrias Treatments Revenue Market Share by Region in 2020
Figure 16. North America Porphyrias Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Porphyrias Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Porphyrias Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Porphyrias Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Porphyrias Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Porphyrias Treatments Market Drivers
Figure 22. Porphyrias Treatments Market Restraints
Figure 23. Porphyrias Treatments Market Trends
Figure 24. Lundbeck Recent Developments and Future Plans
Figure 25. Recordati Rare Diseases Recent Developments and Future Plans
Figure 26. Teva Pharmaceutical Recent Developments and Future Plans
Figure 27. Apotex Recent Developments and Future Plans
Figure 28. Global Porphyrias Treatments Revenue Share by Players in 2020
Figure 29. Porphyrias Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Porphyrias Treatments Revenue Market Share in 2020
Figure 31. Global Top 10 Players Porphyrias Treatments Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Porphyrias Treatments Revenue Share by Type in 2020
Figure 34. Global Porphyrias Treatments Market Share Forecast by Type (2021-2026)
Figure 35. Global Porphyrias Treatments Revenue Share by Application in 2020
Figure 36. Global Porphyrias Treatments Market Share Forecast by Application (2021-2026)
Figure 37. North America Porphyrias Treatments Sales Market Share by Type (2016-2026)
Figure 38. North America Porphyrias Treatments Sales Market Share by Application (2016-2026)
Figure 39. North America Porphyrias Treatments Revenue Market Share by Country (2016-2026)
Figure 40. United States Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Porphyrias Treatments Sales Market Share by Type (2016-2026)
Figure 44. Europe Porphyrias Treatments Sales Market Share by Application (2016-2026)
Figure 45. Europe Porphyrias Treatments Revenue Market Share by Country (2016-2026)
Figure 46. Germany Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Porphyrias Treatments Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Porphyrias Treatments Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Porphyrias Treatments Revenue Market Share by Region (2016-2026)
Figure 54. China Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Porphyrias Treatments Sales Market Share by Type (2016-2026)
Figure 61. South America Porphyrias Treatments Sales Market Share by Application (2016-2026)
Figure 62. South America Porphyrias Treatments Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Porphyrias Treatments Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Porphyrias Treatments Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Porphyrias Treatments Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Porphyrias Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source
世界のポルフィリン症治療市場予測（～2024年） Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system. Scope of the Report: The global Porphyrias Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a …- 世界のポルフィリン症治療薬市場 2021：企業別、地域別、種類・用途別 The Porphyrias Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界のポルフィリン症薬市場予測（～2024年） Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system. Scope of the Report: The worldwide market for Porphyrias Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, f…
- 世界のαマンノシドーシス治療市場 2021：企業別、地域別、種類・用途別 The Alpha Mannosidosis Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の新型コロナウイルス感染症治療市場 2021：企業別、地域別、種類・用途別 The Covid-19 Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…